Anika Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Anika Therapeutics, Inc.‘s stocks are currently a part of 78 hedge funds’ portfolios, which represents 49.96% of the total amount of its stocks outstanding. This makes up a total of 7.27M shares of Anika Therapeutics, Inc.. Compared to the previous quarter, the number fell by -44.48% or -5.82M shares fewer. As for the holding position changes, 29.49% (23) of current hedge fund investors increased the number of shares held, 39.74% (31) of current holders sold a part of the shares held, and 10.26% (8) closed the holdings completely. 10 hedge funds are new holders of Anika Therapeutics, Inc. stock in Q1 2023, it is 12.82% of total holders.
Hedge funds holding Anika Therapeutics (Q2 2018 – Q1 2023)
Q2 2018 | 166 |
---|---|
Q3 2018 | 154 |
Q4 2018 | 157 |
Q1 2019 | 153 |
Q2 2019 | 163 |
Q3 2019 | 191 |
Q4 2019 | 187 |
Q1 2020 | 160 |
Q2 2020 | 154 |
Q3 2020 | 155 |
Q4 2020 | 160 |
Q1 2021 | 144 |
Q2 2021 | 136 |
Q3 2021 | 129 |
Q4 2021 | 125 |
Q1 2022 | 115 |
Q2 2022 | 122 |
Q3 2022 | 114 |
Q4 2022 | 122 |
Q1 2023 | 78 |
Hedge funds changes in Anika Therapeutics positions (Q2 2018 – Q1 2023)
Q2 2018 | 26 | 61 | 51 | 24 | 4 |
---|---|---|---|---|---|
Q3 2018 | 17 | 62 | 45 | 29 | 1 |
Q4 2018 | 26 | 41 | 65 | 24 | 1 |
Q1 2019 | 19 | 76 | 32 | 21 | 5 |
Q2 2019 | 35 | 53 | 50 | 20 | 5 |
Q3 2019 | 40 | 58 | 70 | 12 | 11 |
Q4 2019 | 23 | 74 | 67 | 21 | 2 |
Q1 2020 | 19 | 56 | 57 | 42 | -14 |
Q2 2020 | 16 | 55 | 61 | 21 | 1 |
Q3 2020 | 20 | 51 | 49 | 20 | 15 |
Q4 2020 | 21 | 41 | 68 | 18 | 12 |
Q1 2021 | 16 | 53 | 48 | 31 | -4 |
Q2 2021 | 15 | 46 | 49 | 21 | 5 |
Q3 2021 | 5 | 40 | 50 | 12 | 22 |
Q4 2021 | 12 | 41 | 47 | 15 | 10 |
Q1 2022 | 10 | 43 | 41 | 20 | 1 |
Q2 2022 | 21 | 48 | 30 | 10 | 13 |
Q3 2022 | 9 | 48 | 38 | 18 | 1 |
Q4 2022 | 19 | 36 | 48 | 12 | 7 |
Q1 2023 | 10 | 23 | 31 | 8 | 6 |
Hedge funds changes in Anika Therapeutics stock options (Q2 2018 – Q1 2023)
Q2 2018 | 5,825,000 | 2,253,000 |
---|---|---|
Q3 2018 | 6,588,000 | 1,906,000 |
Q4 2018 | 625,000 | 930,000 |
Q1 2019 | 6,646,000 | 11,638,000 |
Q2 2019 | 4,598,000 | 832,000 |
Q3 2019 | 2,366,000 | 29,798,000 |
Q4 2019 | 1,238,000 | 16,957,000 |
Q1 2020 | 1,827,000 | 4,827,000 |
Q2 2020 | 12,627,000 | 4,781,000 |
Q3 2020 | 26,073,000 | 485,000 |
Q4 2020 | 22,945,000 | 746,000 |
Q1 2021 | 20,833,000 | 762,000 |
Q2 2021 | 315,000 | 0 |
Q3 2021 | 498,000 | 264,000 |
Q4 2021 | 0 | 0 |
Q1 2022 | 213,000 | 264,000 |
Q2 2022 | 24,000 | 0 |
Q3 2022 | 1,973,000 | 431,000 |
Q4 2022 | 2,465,680 | 239,760 |
Q1 2023 | 17,318,000 | 0 |